Trademark search for:

LAMISIL SOLUTION

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2007-05-04 — Application filed
2007-05-08 — Application filed
2007-08-13 — Assigned to examiner
2007-08-14 — Final disposition recorded
2007-08-14 — Final disposition recorded
2007-08-14 — Final disposition recorded
2007-08-17 — Examiners amendment -written
2007-08-17 — Examiners amendment e-mailed
2007-08-17 — Notification of examiners amendment e-mailed
2007-08-17 — Examiner's amendment entered
2007-08-18 — Approved for pub - principal register
2007-09-23 — Assigned to lie
2007-09-23 — Law office publication review completed
2007-10-10 — Notice of publication
2007-10-30 — Published for opposition
2008-01-22 — Noa mailed - sou required from applicant
2008-07-16 — Sou teas extension received
2008-07-16 — Sou extension 1 filed
2008-07-16 — Sou extension 1 granted
2009-02-23 — Application abandoned
2009-02-23 — Application abandoned
2009-02-23 — Final status recorded

Owner Information

Novartis AG
Basel CH

Correspondent

Maury M. Tepper, III WOMBLE CARLYLE SANDRIDGE & RICE, PLLC
PO BOX 831
RALEIGH, NC 27602-0831
UNITED STATES

Filing Details

Filing Date:
2007-05-04

Status Date:
2009-02-23

Category:
Pharmaceuticals

Filing Year:
2007

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.